Go Pro

First Trust NYSE Arca Biotechnology Index Fund (FBT) 10K Form and Latest SEC Filings 2026

First Trust NYSE Arca Biotechnology Index Fund logo
$254.94 -1.13 (-0.44%)
As of 01:20 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest First Trust NYSE Arca Biotechnology Index Fund SEC Filings & Recent Activity

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has submitted 1,166+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 497 submitted on August 13, 2026.

DateFilerForm TypeView
08/13/2026 11:33 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
08/05/2026 1:38 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
08/05/2026 1:39 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
08/05/2026 1:41 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
08/05/2026 1:26 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/31/2026 12:08 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
07/31/2026 11:57 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/31/2026 12:02 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
07/31/2026 12:06 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/31/2026 10:46 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/31/2026 10:29 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/31/2026 10:32 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
07/17/2026 8:32 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
FIRST TRUST PORTFOLIOS LP (1184765) Filed by
Form SCHEDULE 13G/A
07/14/2026 1:11 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
07/10/2026 1:26 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
TRUIST FINANCIAL CORP (92230) Filed by
Form SCHEDULE 13G/A
07/07/2026 1:06 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form CERT
07/07/2026 9:40 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
FIRST TRUST PORTFOLIOS LP (1184765) Filed by
Form SCHEDULE 13G
07/06/2026 3:51 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 8-A12B
06/30/2026 3:32 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BPOS
Post-effective amendment filed pursuant to Securities Act Rule 485(b)
06/30/2026 10:25 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
06/29/2026 2:17 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
06/26/2026 1:14 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
06/25/2026 4:09 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
06/22/2026 2:12 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form CERT
06/22/2026 12:48 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 8-A12B
06/17/2026 3:14 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
06/16/2026 2:25 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
06/11/2026 12:14 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485APOS
06/05/2026 9:01 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
FIRST TRUST PORTFOLIOS LP (1184765) Filed by
Form SCHEDULE 13G/A
06/01/2026 8:57 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
06/01/2026 8:59 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
05/28/2026 12:58 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/28/2026 12:59 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/28/2026 12:10 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 12:16 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 12:16 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 12:16 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/28/2026 11:16 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
05/21/2026 11:33 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/21/2026 11:34 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/18/2026 11:09 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
05/14/2026 11:27 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/14/2026 11:29 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/07/2026 12:11 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
05/01/2026 3:32 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497J
Certification of no change in definitive materials under paragraph (j) of Securities Act Rule 497
04/30/2026 12:23 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/30/2026 12:21 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/30/2026 11:48 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BPOS
Post-effective amendment filed pursuant to Securities Act Rule 485(b)
04/23/2026 10:42 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/23/2026 10:43 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/22/2026 9:51 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
FIRST TRUST PORTFOLIOS LP (1184765) Filed by
Form SCHEDULE 13G/A
04/21/2026 10:28 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form CERT
04/20/2026 12:16 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form CERT
04/20/2026 9:30 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
TRUIST FINANCIAL CORP (92230) Filed by
Form SCHEDULE 13G
04/17/2026 11:38 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 8-A12B
04/17/2026 11:29 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 8-A12B
04/14/2026 8:48 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485APOS
04/13/2026 3:07 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BPOS
Post-effective amendment filed pursuant to Securities Act Rule 485(b)
04/09/2026 12:23 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/09/2026 12:26 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/09/2026 12:29 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
04/07/2026 10:07 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Subject
FIRST TRUST PORTFOLIOS LP (1184765) Filed by
Form SCHEDULE 13G/A
04/01/2026 1:00 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
04/01/2026 1:02 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
Barricks gold output fell from 2 million ounces to 719000 (Ad)

Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-largest miner running on fumes. Newmont's $15 billion purchase of Newcrest, the largest mining deal in history, still couldn't keep output growing, proof that majors must keep buying to survive. With record cash flows and shrinking mines, gold majors are positioned to launch a wave of acquisitions targeting the best junior assets.tc pixel

See the top three gold buyout targets to watch now
03/27/2026 2:26 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/27/2026 2:28 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/27/2026 2:30 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/20/2026 1:35 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
03/20/2026 11:37 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/20/2026 11:33 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/20/2026 11:35 AM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 485BXT
03/16/2026 12:57 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497
Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
03/16/2026 12:58 PM
First Trust NYSE Arca Biotechnology Index Fund (1329377) Filer
Form 497K
Summary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(k)
(Data available from 1/1/2016 forward)

First Trust NYSE Arca Biotechnology Index Fund SEC Filings - Frequently Asked Questions

First Trust NYSE Arca Biotechnology Index Fund (FBT) has submitted 1,166+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 497 submitted on August 13, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSEARCA:FBT) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners